(Q35871489)

10 August 2017

1 reference

title

Mast cells and mast cell mediators as targets of dietary supplements (English)

1 reference

10 August 2017

0 references

Theoharis C Theoharides

series ordinal

1

object named as

Theoharis C Theoharides

1 reference

10 August 2017

2

Leonard Bielory

1 reference

10 August 2017

1 August 2004

1 reference

Annals of Allergy, Asthma & Immunology

10 August 2017

1 reference

10 August 2017

93

1 reference

10 August 2017

2 Suppl 1

1 reference

10 August 2017

S24-34

1 reference

Complementary medicine for the allergist.

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Complementary/alternative medicine: we need to become more knowledgeable

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cell involvement in interstitial cystitis: a review of human and experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

New agents for the medical treatment of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Replacing myth and prejudice with scientific facts about complementary and alternative medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

New concepts about the mast cell

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cells: beyond IgE.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mediators of immediate hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Human mast cells and basophils as sources of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Critical role of mast cells in inflammatory diseases and the effect of acute stress

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

What is the physiological function of mast cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The mast cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cells and stress--a psychoneuroimmunological perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Differential release of serotonin and histamine from mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?".

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Opiates, mast cells and histamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Agents that Release Histamine from Mast Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Acetylsalicylate and salicylates in foods

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Histamine poisoning associated with eating tuna burgers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Histamine fish poisoning revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Medicinal herbs: answers and advice, part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Medicinal herbs: answers and advice, Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Internet marketing of herbal products

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Drugs alias dietary supplements

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

1 reference

7 January 2021

Herbal therapy: what a clinician needs to know to counsel patients effectively

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Side-effects of complementary and alternative medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Herbal medicines and perioperative care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Effectiveness of St John's wort in major depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Drug-grapefruit juice interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Ginkgo for memory enhancement: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Green tea and the risk of gastric cancer in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Does an apple a day keep breast cancer away?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Reducing the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Wild-mushroom intoxication as a cause of rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Chondroitin sulphate inhibits connective tissue mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Aloe vera and the inflamed synovial pouch model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The costs of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Medical management of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Regular review: medical management of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Articular mastocytosis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Synovial mast cell responses during clinical improvement in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cells as a target of rheumatoid arthritis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The Oriental medicine "Cool-Cool (Cool-X-A)" inhibits inflammatory cytokine production and migration in mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Production of interleukin-6 by human mast cells and basophilic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interleukin 6 is required for the development of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interleukin 6 plays a key role in the development of antigen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cells: a cellular link between autoantibodies and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The relation between stress and disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Stress and rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Use of complementary and alternative medicine by pediatric rheumatology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Development of a new instrument for rheumatoid arthritis: the Cedars-Sinai Health-Related Quality of Life instrument (CSHQ-RA).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Why are clinical trials of glucosamine no longer uniformly positive?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The effect of oral glucosamine sulfate on insulin sensitivity in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Microbial adherence to and invasion through proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Diagnosis of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interstitial cystitis early diagnosis, pathology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Mast cell activation in sterile bladder and prostate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interstitial cystitis: a neuroimmunoendocrine disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Epidemiology of interstitial cystitis: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

The natural history of interstitial cystitis: a survey of 374 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Current management of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Stress-induced bladder mast cell activation: implications for interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Adenocarcinoid of ileum and appendix, incidentally discovered during exploratory laparotomy for gastric MALT lymphoma, with subsequent diffuse prostatic metastases: report of a case with light, immunohistochemical, and electron microscopic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

PENTOSANPOLYSULFATE INHIBITS MAST CELL HISTAMINE SECRETION AND INTRACELLULAR CALCIUM ION LEVELS:: AN ALTERNATIVE EXPLANATION OF ITS BENEFICIAL EFFECT IN INTERSTITIAL CYSTITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Hydroxyzine inhibits neurogenic bladder mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Complementary and alternative medicine herbal therapies for atopic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Petasins in the treatment of allergic diseases: results of preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

Screening of several Indonesian medicinal plants for their inhibitory effect on histamine release from RBL-2H3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961484-6

7 January 2021

10.1016/S1081-1206(10)61484-6

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15330009